Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
07/01/2004 | WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists |
07/01/2004 | WO2004054987A1 Cathepsin cysteine protease inhibitors and their use |
07/01/2004 | WO2004054986A2 Process for the preparation of pyrimidine compounds |
07/01/2004 | WO2004054984A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
07/01/2004 | WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
07/01/2004 | WO2004054617A1 Preventives and/or remedies for central diseases |
07/01/2004 | WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
07/01/2004 | WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
07/01/2004 | WO2004039774A3 Mitotic kinesin inhibitors |
07/01/2004 | WO2004026237A3 Compounds for the treatment of premature ejaculation |
07/01/2004 | WO2004018058A3 Compounds, compositions, and methods |
07/01/2004 | WO2004016086B1 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
07/01/2004 | US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity |
07/01/2004 | US20040127708 antiviral activities; aids treatment |
07/01/2004 | US20040127707 Novel phthalazinones |
07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
07/01/2004 | US20040127536 Indazole Derivatives |
07/01/2004 | US20040127530 treating gram-negative microbial infections |
07/01/2004 | US20040127528 Metalloproteinase inhibitors |
07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
07/01/2004 | US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders |
07/01/2004 | US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia |
07/01/2004 | US20040127507 Imidazolidine compounds |
07/01/2004 | US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal |
07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
07/01/2004 | US20040127501 Therapeutic agents useful for treating pain |
07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
07/01/2004 | US20040127484 Novel bicyclic inhibitors of hormone sensitive lipase |
07/01/2004 | US20040127477 Heterocyclic glycyl beta-alanine derivatives |
07/01/2004 | US20040123400 Human hair; using mixture of dye with oxidizer and coupler |
07/01/2004 | DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments |
07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
07/01/2004 | CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
07/01/2004 | CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists |
07/01/2004 | CA2508838A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
07/01/2004 | CA2508045A1 Novel compounds having selective inhibiting efect at gsk3 |
07/01/2004 | CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
06/30/2004 | EP1432699A1 Pyridylfurans and pyrroles as raf kinase inhibitors |
06/30/2004 | EP1432693A2 Mch receptor antagonists |
06/30/2004 | EP1432692A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
06/30/2004 | EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
06/30/2004 | EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
06/30/2004 | EP1432421A1 Quinoline derivatives as neuropeptide y antagonists |
06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
06/30/2004 | CN1509286A Metalloproteinase inhibitors |
06/30/2004 | CN1509285A Substituted aryl ketons |
06/30/2004 | CN1509284A Delta1 pyrrolines |
06/30/2004 | CN1509276A Metalloproteinase inhibitors |
06/30/2004 | CN1509275A Metalloproteinase inhibitors |
06/30/2004 | CN1509274A Metallo proteinase inhibitors |
06/30/2004 | CN1509273A Metalloproteinase inhibitors |
06/30/2004 | CN1509272A Metalloproteinase inhibitors |
06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
06/30/2004 | CN1155596C New phenylpiperazines |
06/30/2004 | CN1155595C Substituted pyrroles as antiproliferative agents for treatment of cancer |
06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
06/30/2004 | CN1155569C Indolin derivs. as sun protection agents |
06/30/2004 | CN1155567C Antipsychotic indolyl derivatives |
06/30/2004 | CN1155312C Herbicidal synergic composition and method for controlling weed |
06/30/2004 | CN1155311C Herbicidal synergic composition and method for controlling weed |
06/29/2004 | US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability |
06/29/2004 | US6756394 Small molecule inhibitors of necrosis |
06/29/2004 | US6756391 Antiviral compounds |
06/29/2004 | US6756386 Such as 1-methyl-3-oxy-(5-chloro-3-pyridyl)-piperidine; cholinergic system of central nervous system; pain, inflammation |
06/29/2004 | US6756385 Imidazole derivatives |
06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
06/29/2004 | US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc |
06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
06/24/2004 | WO2004052870A1 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography |
06/24/2004 | WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators |
06/24/2004 | WO2004052868A1 Pyrazine-based tubulin inhibitors |
06/24/2004 | WO2004052866A1 3-phenyl-cinnoline homologue and antitumor agent containing the same |
06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
06/24/2004 | WO2004052856A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
06/24/2004 | WO2004052852A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
06/24/2004 | WO2004052304A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
06/24/2004 | WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment |
06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
06/24/2004 | WO2003094839A8 Pyrimidinone compounds, compositions and methods |
06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
06/24/2004 | WO2003072056A3 Intranasal administration of mc4-r agonists |
06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/24/2004 | US20040122238 for color photography |
06/24/2004 | US20040122234 Growth Hormone secretagogues |